| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 01/29/2009 | US20090029864 Method For Screening Toxin Neutralizing Peptide, STX2 Inhibiting Peptide And Verotoxin Neutralizing Agent |
| 01/29/2009 | US20090029468 Zinc finger binding domains for cnn |
| 01/29/2009 | US20090029460 Neoplasm-specific polypeptides and their uses |
| 01/29/2009 | US20090029420 solubility tag characterized by an increase in acid resistance; production and recovery of fusion peptide; inclusion body tag's resistance to acid hydrolysis facilitates easier and cleaner separation of the peptide of interest after acid hydrolysis |
| 01/29/2009 | US20090029413 have desirable characteristics regarding adherence to the substrate, durability, hydrophilicity, wettability, biocompatibility and permeability and are thus particularly useful as ophthalmic devices such as contact lenses; low spoilation with respect to cell debris, cosmetics, tear components, lipids |
| 01/29/2009 | US20090029412 for the generation of insoluble fusion peptides; used for the expression and recovery of any bioactive peptides and proteins that are recombinantly expressed |
| 01/29/2009 | US20090029343 Methods for isolation and analysis of sialylated and phosphorylated peptides |
| 01/29/2009 | US20090028889 Novel Polypeptide Ligands For Toll-Like Receptor 2 (TLR2) |
| 01/29/2009 | US20090028885 Citrulline peptides derived from fibrin and recognized by rheumatoid arthritis specific autoantibodies, and the use thereof |
| 01/29/2009 | US20090028867 Antagonists Specific For Denatured Collagen And Methods Of Using Same |
| 01/29/2009 | US20090028813 Methods for Treating Body Tissue |
| 01/29/2009 | CA2694461A1 Antibiotic peptides |
| 01/28/2009 | EP1725580B1 Isosteric transformation |
| 01/28/2009 | EP1446426B1 Peptide purification by means of metal ion affinity chromatography |
| 01/28/2009 | EP0675953B1 Soluble peptides having constrained, secondary conformation in solution and method of making same |
| 01/28/2009 | CN101356186A Prion-specific peptoid reagents |
| 01/28/2009 | CN101353371A H5 subtype avian influenza virus neutralization epitope peptide mimics and uses thereof |
| 01/28/2009 | CN100455593C Process for synthesis of thymopentin |
| 01/27/2009 | US7482429 cyclic depsipeptides and/or mimetics, used as anticarcinogenic agents, formed by cyclization of polypeptides |
| 01/27/2009 | US7482329 Structure-based methods and compositions useful in designing, identifying, and producing molecules which act as functional modulators of TDF-like (tissue differentiation factor) receptors; methods of detecting, preventing, and treating TDF-associated disorders |
| 01/27/2009 | US7482328 an artificially synthesized antimicrobial polypeptide that does not occur in nature contains in its peptide chain one or more types of nuclear localization signal sequences (NLSs); for drug resistance bacteria |
| 01/27/2009 | US7482008 Human T cell reactive feline protein (TRFP) isolated from house dust and uses therefor |
| 01/27/2009 | US7481999 Compounds and methods for modulating OB-cadherin-mediated function |
| 01/27/2009 | CA2319206C Peptide structures and their use in diagnosis of herpes simplex virus type 2 |
| 01/27/2009 | CA2236837C Detection of mammary tumor virus-like sequences in human breast cancer |
| 01/27/2009 | CA2191951C Monoamine, diamide, thiol-containing metal chelating agents |
| 01/27/2009 | CA2173846C Cntf family antagonists |
| 01/22/2009 | WO2009012472A2 Methods and compositions for treating conditions |
| 01/22/2009 | WO2009010765A2 Lantibiotic-based compounds having antimicrobial activity |
| 01/22/2009 | WO2009010733A2 Peptide gap junction modulators |
| 01/22/2009 | WO2009010356A1 New peptide whitening agents and cosmetic compositions comprising the same |
| 01/22/2009 | WO2001092300A9 Chimeric gfp-aequorin as bioluminescent ca++ reporters at the single cell level |
| 01/22/2009 | US20090023898 Methods and compositions for protein purification |
| 01/22/2009 | US20090023896 Compounds with a sulphonamide group and pharmaceutical compositions containing these compounds |
| 01/22/2009 | US20090023895 Hla-binding peptide, precursor thereof, and dna fragment and recombinant vector coding for said hla-binding peptide |
| 01/22/2009 | US20090023894 Neutralizing Antibody Against HGF |
| 01/22/2009 | US20090023892 Enzymatic reactions in the presence of keto acids |
| 01/22/2009 | US20090023652 Polycationic calcium modulator peptides for the treatment of hyperparathyroidism and hypercalcemic disorders |
| 01/22/2009 | US20090023648 Methods for Treating Body Tissue |
| 01/22/2009 | US20090023641 Cyclic Antimicrobial Peptides |
| 01/22/2009 | US20090023630 Methods and Means for Use in Diagnostics and Treatment of Diabetes |
| 01/22/2009 | US20090023627 Compositions and methods for alzheimer's disease |
| 01/22/2009 | US20090023215 Novel reagents for transfection of eukaryotic cells |
| 01/22/2009 | US20090023184 Novel Tachykinin Peptides, Precursor Peptides Thereof And Genes Encoding The Same |
| 01/22/2009 | US20090022782 Blood Retainable Device Exhibiting Selective Degradability in Tumor Tissue |
| 01/22/2009 | US20090022743 Peptides Effective in the Treatment of Tumors and Other Conditions Requiring the Removal or Destruction of Cells |
| 01/22/2009 | US20090022674 Cosmetic or dermatological preparations comprising oligopeptides for lightening the skin of age marks and/or for preventing tanning of the skin, in particular tanning of the skin caused by uv radiation |
| 01/22/2009 | US20090022664 Radiolabelling via fluorination of aziridines |
| 01/22/2009 | US20090022623 Peptides Capable of Functioning as Mimotopes for Hormonal Analytes |
| 01/22/2009 | CA2693051A1 Lantibiotic-based compounds having antimicrobial activity |
| 01/21/2009 | EP2017283A1 Peptide |
| 01/21/2009 | EP2016950A1 Pharmaceutical composition comprising an exedin-4 peptide |
| 01/21/2009 | EP2016934A1 Peptide-based body surface reagents for personal care |
| 01/21/2009 | EP2016094A1 Novel analogues of antimicrobial and anticancer peptide synthesized and produced from gaegurin 5 |
| 01/21/2009 | EP2016093A1 Peptides for use in diagnosing the presence of ruptured atherosclerotic lesions in an individual |
| 01/21/2009 | EP1904517B1 Artificial protein for absolute quantification of proteins and uses thereof |
| 01/21/2009 | EP1421106B1 Catalysis of the cis/trans isomerisation of secondary amide peptide compounds |
| 01/21/2009 | EP0912195B1 Vaccine comprising antigens bound to carriers through labile bonds |
| 01/21/2009 | CN101348521A Aminoacid mimic epitope of human B lymphocyte stimulating factor receptor and use thereof |
| 01/21/2009 | CN100453554C Suppressing peptide of heptitis B virus polymerase lymerase protein YMDD functionalized area and its uses |
| 01/20/2009 | US7479538 Improved in vitro binding affinity for HIV-1 gp 120 and gp 41, and human CD4 cells |
| 01/20/2009 | US7479372 Beta-secretase substrates and uses thereof |
| 01/20/2009 | CA2264570C Invasion-inducing agents and invasion-inhibitors for use in wound healing and cancer |
| 01/20/2009 | CA2108473C Heregulins (hrgs) binding proteins of p185erb2 |
| 01/15/2009 | WO2009009613A2 Novel ion channel-forming peptides |
| 01/15/2009 | WO2009006680A1 Epitopes of herpes simplex virus |
| 01/15/2009 | WO2008110578A3 Markers, antibodies and recombinant scfvs for mesenchymal stem cell-sub-populations and osteoclasts |
| 01/15/2009 | WO2008107722A3 Peptides, compositions and uses thereof |
| 01/15/2009 | WO2008097854A4 Method and substances for treating hpv infection |
| 01/15/2009 | WO2008071679A9 Fibrin binding peptide conjugates for diagnostic and therapeutic applications. |
| 01/15/2009 | US20090018086 Monomethylvaline Compounds Having Phenylalanine Side-Chain Replacements at the C-Terminus |
| 01/15/2009 | US20090018085 Use of a GnRH antagonist peptide in the treatment of sex hormone-dependent diseases |
| 01/15/2009 | US20090018083 Methods and compositions for inhibition of bcl6 repression |
| 01/15/2009 | US20090018060 Thymus-specific protein |
| 01/15/2009 | US20090017053 Composition and Method for Preventing or Treating a Virus Infection |
| 01/15/2009 | US20090017052 Methods of determining lethality of pathogens and malignancies involving replikin peak genes |
| 01/15/2009 | US20090016959 Drug delivery across the blood-brain barrier using polypeptides; neurological diseases; aprotinin |
| 01/15/2009 | CA2692037A1 Il-23 receptor antagonists and uses thereof |
| 01/14/2009 | EP2014673A1 Tumour-associated peptides which bind to MHC molecules |
| 01/14/2009 | EP2014310A2 KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy |
| 01/14/2009 | EP2013228A1 Methods of inducing apoptosis of cancerous cells using apoptin derivatives |
| 01/14/2009 | EP2012810A2 Solid support reagents for synthesis |
| 01/14/2009 | EP1858914A4 Peptide networks |
| 01/14/2009 | EP1753776B1 Camptothecins conjugated in position 7 to cyclic peptides as cytostatic agents |
| 01/14/2009 | EP1730172A4 Methods and compositions for the treatment of gastrointestinal disorders |
| 01/14/2009 | EP1689771B1 Biologically active peptides comprising isoleucyl-valyl-threonyl-asparaginyl-threonyl-threonine (ivtntt) |
| 01/14/2009 | EP1377305B1 Tryptophanyl-trna synthetase derived polypeptides useful for the regulation of an-giogenesis |
| 01/14/2009 | EP0948539B1 Peptides and compounds that bind to a receptor |
| 01/14/2009 | CN100451655C Method for the diagnosis of cancers by measuring the changes of glycosylation of proteins related to tumorigenesis and metastasis and kit for diagnosis of cancers using the same |
| 01/13/2009 | US7476721 Modified cytokines for use in cancer therapy |
| 01/13/2009 | US7476657 Appear to function at least in part by inhibiting G2 cell cycle checkpoint; useful in treating metastatic and non-metastatic solid or liquid tumors |
| 01/13/2009 | US7476650 Enzyme inhibition |
| 01/13/2009 | US7476649 Antiproliferative and antiviral proteins and peptides |
| 01/08/2009 | WO2009006638A2 Peptides facilitating retrograde transport and their uses |
| 01/08/2009 | WO2009006246A1 Use of tight junction antagonists in the treatment of acute long injury and acute respiratory distress syndrome |
| 01/08/2009 | WO2009005783A1 Peptides, compositions and methods for reducing beta-amyloid-mediated apoptosis |
| 01/08/2009 | WO2009005151A1 Novel lipid peptide and hydrogel |
| 01/08/2009 | WO2009004315A1 Isolated peptides and uses thereof |
| 01/08/2009 | WO2009003284A1 Novel peptides, use thereof in cosmetic and cosmeceutic applications, and compositions comprising same |
| 01/08/2009 | WO2008121767A3 Stitched polypeptides |